← Open Payments lookup

RENATA ZELVYTE: Open Payments

NPI 1821455999 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,201 in 90 payments from 11 companies in 2025. Trend: 2023 $1,153 · 2024 $1,724 · 2025 $2,201

Food & beverage: $2,198Education: $4
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$401
Janssen Pharmaceuticals, Inc7$347
Alkermes, Inc.13$311
E.R. Squibb & Sons, L.L.C.21$236
ABBVIE INC.11$216
Teva Pharmaceuticals USA, Inc.7$155
Neurocrine BioSciences, Inc.6$148
Janssen Scientific Affairs, LLC1$124
Lundbeck LLC6$122
Otsuka America Pharmaceutical, Inc.5$100

Products named: CAPLYTA, INVEGA SUSTENNA, ARISTADA, COBENFY, VRAYLAR, INGREZZA, REXULTI, UZEDY.

Industry payments across TX — which companies pay providers there.